| Literature DB >> 35021989 |
Allison M H Foy1,2, Rebekah L Hudock1, Ryan Shanley3, Elizabeth I Pierpont4.
Abstract
BACKGROUND: RASopathies are genetic syndromes that result from pathogenic variants in the RAS-MAPK cellular signaling pathway. These syndromes, which include neurofibromatosis type 1, Noonan syndrome, cardiofaciocutaneous syndrome, and Costello syndrome, are associated with a complex array of medical and behavioral health complications. Despite a heightened risk for social challenges and autism spectrum disorder (ASD), few studies have compared different aspects of social behavior across these conditions. It is also unknown whether the underlying neuropsychological characteristics that contribute to social competence and socially empathetic ("prosocial") behaviors differ in children with RASopathies as compared to children with nonsyndromic (i.e., idiopathic) ASD.Entities:
Keywords: Autism; Cardiofaciocutaneous syndrome; Costello syndrome; Neurofibromatosis type 1; Noonan syndrome; Prosocial; RASopathy; Social competence; Social function; Social skills
Mesh:
Year: 2022 PMID: 35021989 PMCID: PMC8753327 DOI: 10.1186/s11689-021-09414-w
Source DB: PubMed Journal: J Neurodev Disord ISSN: 1866-1947 Impact factor: 4.025
Fig. 1Flow diagram for study participants
RAS-MAPK genes affected among participants with RASopathies
| Molecular testing % ( | Confirmed variants among those tested | |
|---|---|---|
| CFCS | 100% [ | BRAF (60%) MAP2K1 (MEK1) (28%) MAP2K2 (MEK2) (5%) YWHAZ (5%) Unknown (3%) |
| CS | 100% [ | HRAS (100%) |
| NF1 | 70% [ | NF1 (98%) Unknown (2%) |
| NS | 93% [ | PTPN11 (57%) RAF1 (9%) SOS1 (9%) KRAS (6%) RIT1 (4%) SOS2 (3%) BRAF (3%) PPP1CB (2%) A2ML1 (1%) Unknown (6%) |
Demographics of study participants
| NF1 ( | NS ( | CFCS ( | CS ( | RASopathy ( | iASD ( | |
|---|---|---|---|---|---|---|
| Participant demographics | ||||||
| Age of child (M (SD)) | 9.8 (4.37) | 9.2 (4.21) | 8.8 (4.10) | 11.0 (4.21) | 9.5 (4.26) | 10.4 (3.67) |
| Gender ( | 36 (51) | 37 (51) | 17 (43) | 9 (50) | 99 (49) | 80 (73) |
| Race ( | ||||||
| American Indian or Alaska Native | 0 (0) | 1 (1) | 1 (3) | 0 (0) | 2 (1) | 5 (5) |
| Asian | 2 (3) | 4 (6) | 3 (8) | 2 (11) | 11 (5) | 5 (5) |
| Black or African American | 4 (6) | 3 (4) | 1 (3) | 0 (0) | 8 (4) | 5 (5) |
| Native Hawaiian or Other Pacific Islander | 1 (1) | 1 (1) | 0 (0) | 2 (11) | 4 (2) | 2 (2) |
| White | 65 (92) | 69 (95) | 37 (93) | 17 (94) | 188 (93) | 96 (88) |
| Other | 1 (1) | 1 (1) | 2 (5) | 2 (11) | 6 (3) | 6 (5) |
| Ethnicity (% Hispanic/Latinx) | 13 (18) | 4 (6) | 3 (8) | 1 (6) | 21 (10) | 15 (14) |
| Medical complications ( | ||||||
| Preterm birth | 6 (9) | 12 (16) | 13 (33) | 8 (44) | 39 (19) | 9 (8) |
| Seizures | 10 (14) | 7 (10) | 20 (50) | 2 (11) | 39 (19) | 1 (1) |
| Tumor | 31 (44) | 4 (6) | 1 (3) | 0 (0) | 36 (18) | 0 (0) |
| Visual impairment | 20 (29) | 37 (51) | 29 (73) | 12 (67) | 98 (49) | 20 (19) |
| Hearing impairment | 4 (6) | 16 (22) | 10 (25) | 0 (0) | 30 (15) | 2 (2) |
Psychiatric and neurodevelopmental diagnosis prevalence estimates in the literature as compared to this study cohort (%)
| NF1 ( | NS ( | CFCS ( | CS ( | iASD ( | |
|---|---|---|---|---|---|
| Estimates | 11–26 [ | 0–30 [ | 9–54 [ | 11–26 [ | 100 |
| Our study | 16 | 10 | 23 | 6 | 100 |
| Estimates | 39 [ | 34–48 [ | 47–89 [ | 38 [ | 28–76 [ |
| Our study | 41 | 25 | 15 | 6 | 47 |
| Estimates | 18–21 [ | 7–8 [ | 6 [ | 20–50 [ | 32–79 [ |
| Our study | 18 | 14 | 28 | 22 | 37 |
| Estimates | – | – | 12 [ | – | 1–56 [ |
| Our study | 11 | 6 | 0 | 0 | 13 |
| Estimates | 4–8 [ | 6–23 [ | 90–100 [ | 78–100 [ | 33 [ |
| Our study | 10 | 15 | 63 | 67 | 11 |
– No research available; *for males (primarily separation anxiety)
Social and behavioral ratings of children with RASopathies or idiopathic ASD
| RASopathy | Idiopathic ASD | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Measure | Mean | (SD) | % Clinical impairment (≥ 2 SD below mean) | Mean | (SD) | % Clinical impairment (≥ 2 SD below mean) | Mean difference (95% CI) | |||
| 149 | 39.57 | (11.10) | 19 | 87 | 30.49 | (7.64) | 48 | 9.08 | 6.43 to 11.73 | |
| 149 | 45.30 | (11.16) | 8 | 88 | 32.99 | (9.39) | 40 | 12.31 | 9.52 to 15.10 | |
| 180 | 1.23 | (1.45) | 29 | 97 | 1.32 | (1.29) | 29 | − 0.09 | − .44 to .26 | |
| 180 | 0.48 | (1.15) | 11 | 97 | 0.71 | (1.10) | 17 | − 0.23 | − .51 to .06 | |
| 180 | 1.33 | (1.15) | 32 | 97 | 1.59 | (1.03) | 46 | − 0.26 | − .54 to .01 | |
| 180 | 1.33 | (1.42) | 38 | 97 | 2.21 | (1.11) | 58 | − 0.87 | − 1.2 to − .55 | |
| 180 | 0.83 | (1.25) | 22 | 97 | 1.79 | (1.24) | 44 | − 0.96 | − 1.27 to − .65 | |
SEARS scores are reported in T-scores with a mean of 50 and a standard deviation of 10. Higher SEARS scores indicate fewer problems; SDQ scores are reported in z-scores with a mean of 0 and a standard deviation of 1. Higher SDQ scores indicate more problems
Fig. 2Social Competence and Empathy scores for children with RASopathies and children with idiopathic ASD
Results of multivariable regression models for prediction of SEARS Social Competence and Empathy scales
| RASopathy ( | Idiopathic ASD ( | |||
|---|---|---|---|---|
| Model | Regression coefficient | (95% CI) | Regression coefficient | (95% CI) |
| 34.86 | (22.78 to 46.93) | 19.94 | (10.55 to 29.33) | |
| − 2.55 | (− 3.78 to −1.33) | − 0.17 | (− 1.5 to 1.17) | |
| − 1.87 | (− 3.35 to − .38) | − 0.82 | (− 2.49 to .84) | |
| 1.21 | (− .04 to 2.45) | 1.42 | (.41 to 2.43) | |
| 19.75 | (7.57 to 31.93) | 16.64 | (6.31 to 26.97) | |
| 0.80 | (− .43 to 2.04) | 1.83 | (.35 to 3.31) | |
| − 2.43 | (− 3.93 to − .93) | − 3.01 | (− 4.85 to −1.18) | |
| 3.12 | (1.86 to 4.38) | 2.18 | (1.07 to 3.30) | |